COVID-19 vaccine boosters could mean billions for drugmakers

COVID-19 vaccine boosters could mean billions for
drugmakers 1

FILE – In this March 2021 photo provided by Pfizer, a technician works on a line for packaging preparation for the Pfizer-BioNTech COVID-19 vaccine at the company’s facility in Puurs, Belgium. Billions more in profits are at stake for some vaccine makers as the U.S. moves toward dispensing COVID-19 booster shots to shore up Americans’ protection against the virus. (AP)

Read the Full Article

Prepare Now Before its too Late

Discover where products are available & compare prices

Joe Biden gets a COVID-19 booster shot in front of cameras
Massachusetts extends school mask mandate until at least Nov. 1

You might also like
Menu